You are here

Article info

Article menu
Download PDFPDF
Commentary
Fair prices for new direct-acting antiviral agents (DAAs) to make treatment for all affordable

Authors

  • Sylvie Deuffic-Burban Inserm, IAME, UMR 1137, F-75018 Paris, France Univ Paris Diderot, IAME, UMR1137, Sorbonne Paris Cité, F-75018 Paris, France Inserm U995, Univ Lille2—Lille Nord de France, Lille, France PubMed articlesGoogle scholar articles
  • Yazdan Yazdanpanah Inserm, IAME, UMR 1137, F-75018 Paris, France Univ Paris Diderot, IAME, UMR1137, Sorbonne Paris Cité, F-75018 Paris, France Service de Maladies infectieuses et tropicales, Hôpital Bichat Claude Bernard, Paris, France PubMed articlesGoogle scholar articles
  1. Correspondence to Sylvie Deuffic-Burban, Inserm UMR1137 & U995, 152 rue du Docteur Yersin, Loos 59120, France; sylvie.burban{at}inserm.fr
View Full Text

Citation

Deuffic-Burban S, Yazdanpanah Y
Fair prices for new direct-acting antiviral agents (DAAs) to make treatment for all affordable
Gut 2015;64:1190-1191.

Publication history

  • Received November 25, 2014
  • Revised December 8, 2014
  • Accepted December 10, 2014
  • First published January 7, 2015.
Online issue publication 
April 18, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions